ECG遠隔測定装置の世界市場：洞察、競合情勢、市場予測：2030年

世界のECG遠隔測定装置の市場規模は、2024年から2030年までの予測期間中に7.29%のCAGRで拡大すると予測されています。ECG遠隔測定装置の需要は、主に世界中で冠動脈性心疾患の有病率が上昇していることが後押ししています。さらに、慢性疾患患者の増加、集中治療室への入院患者の増加、心臓リズムの自己評価に対する意識の高まり、遠隔医療に対する需要の増加、製品開拓における技術革新などが、2024年から2030年までの予測期間におけるECG遠隔測定装置市場全体の成長に寄与しています。

ECG遠隔測定装置市場は、さまざまな要因によって製品需要が伸びていますが、主要な要因の1つは、脳卒中、心臓発作、アテローム性動脈硬化症などの心疾患の有病率の上昇です。例えば、米国疾病予防管理センター（CDC）2022によると、毎年米国では約80万5,000人が心臓発作を起こし、このうち60万5,000人が初めて心臓発作を起こし、20万件近くがすでに心臓発作を起こした人に再発しています。このように、心臓発作の症例が増加することで、心臓の継続的モニタリングに使用されるモバイルECG遠隔測定装置の需要が増加します。

当レポートでは、世界のECG遠隔測定装置市場について調査し、市場の概要とともに、製品タイプ別、タイプ別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 ECG遠隔測定装置市場レポートのイントロダクション

第2章 市場エグゼクティブサマリー

第3章 規制分析

• 米国
• 欧州
• 日本
• 中国

第4章 ECG遠隔測定装置市場の主な要因分析

• ECG遠隔測定装置市場の促進要因
• ECG遠隔測定装置市場の抑制要因と課題
• ECG遠隔測定装置市場の機会

第5章 ECG遠隔測定装置市場におけるポーターのファイブフォース分析

第6章 ECG遠隔測定装置市場に対するCOVID-19の影響分析

第7章 ECG遠隔測定装置市場の概要

• 製品タイプ別
• タイプ別
• 用途別
• エンドユーザー別
• 地域別

第8章 ECG遠隔測定装置市場の企業と製品プロファイル

• NIHON KOHDEN CORPORATION
• Baxter
• Boston Scientific Corporation
• GE HealthCare
• Koninklijke Philips N.V. (BioTelemetry)
• Zio by iRhythm Technologies, Inc.
• Aerotel Medical Systems Ltd
• Medtronic
• Mindray Medical India Pvt. Ltd.
• Medicalgorithmics
• Scottcare cardiovascular solution
• ZOLL Medical Corporation
• CONTEC MEDICAL SYSTEMS CO., LTD.
• dmiecg
• Perlong Medical Equipment Co., Ltd.
• QT Medical Inc.

第9章 KOL の見解

第10章 プロジェクトのアプローチ

第11章 DelveInsightについて

第12章 免責事項とお問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: COVID-19 Impact Analysis
• Table 3: ECG Telemetry Device Market in Global (2021-2030)
• Table 4: ECG Telemetry Device Market in Global by Product Type (2021-2030)
• Table 5: ECG Telemetry Device Market in Global by Type (2021-2030)
• Table 6: ECG Telemetry Device Market in Global by Application (2021-2030)
• Table 7: ECG Telemetry Device Market in Global by End-User (2021-2030)
• Table 8: ECG Telemetry Device Market in Global by Geography (2021-2030)
• Table 9: ECG Telemetry Device Market in North America (2021-2030)
• Table 10: ECG Telemetry Device Market in North America by Country (2021-2030)
• Table 11: ECG Telemetry Device Market in the US (2021-2030)
• Table 12: ECG Telemetry Device Market in Canada (2021-2030)
• Table 13: ECG Telemetry Device Market in Mexico (2021-2030)
• Table 14: ECG Telemetry Device Market in Europe (2021-2030)
• Table 15: ECG Telemetry Device Market in Europe by Country (2021-2030)
• Table 16: ECG Telemetry Device Market in France (2021-2030)
• Table 17: ECG Telemetry Device Market in Germany (2021-2030)
• Table 18: ECG Telemetry Device Market in the United Kingdom (2021-2030)
• Table 19: ECG Telemetry Device Market in Italy (2021-2030)
• Table 20: ECG Telemetry Device Market in Spain (2021-2030)
• Table 21: ECG Telemetry Device Market in the Rest of Europe (2021-2030)
• Table 22: ECG Telemetry Device Market in Asia-Pacific (2021-2030)
• Table 23: ECG Telemetry Device Market in Asia-Pacific by Country (2021-2030)
• Table 24: ECG Telemetry Device Market in China (2021-2030)
• Table 25: ECG Telemetry Device Market in Japan (2021-2030)
• Table 26: ECG Telemetry Device Market in India (2021-2030)
• Table 27: ECG Telemetry Device Market in Australia (2021-2030)
• Table 28: ECG Telemetry Device Market in South Korea (2021-2030)
• Table 29: ECG Telemetry Device Market in Rest of Asia-Pacific (2021-2030)
• Table 30: ECG Telemetry Device Market in the Rest of the World (2021-2030)
• Table 31: ECG Telemetry Device Market in RoW by Region (2021-2030)
• Table 32: ECG Telemetry Device Market in the Middle East (2021-2030)
• Table 33: ECG Telemetry Device Market in Africa (2021-2030)
• Table 34: ECG Telemetry Device Market in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: COVID-19 Impact Analysis
• Figure 3: ECG Telemetry Device Market in Global (2021-2030)
• Figure 4: ECG Telemetry Device Market in Global by Product Type (2021-2030)
• Figure 5: ECG Telemetry Device Market in Global by Type (2021-2030)
• Figure 6: ECG Telemetry Device Market in Global by Application (2021-2030)
• Figure 7: ECG Telemetry Device Market in Global by End-User (2021-2030)
• Figure 8: ECG Telemetry Device Market in Global by Geography (2021-2030)
• Figure 9: ECG Telemetry Device Market in North America (2021-2030)
• Figure 10: ECG Telemetry Device Market in North America by Country (2021-2030)
• Figure 11: ECG Telemetry Device Market in the US (2021-2030)
• Figure 12: ECG Telemetry Device Market in Canada (2021-2030)
• Figure 13: ECG Telemetry Device Market in Mexico (2021-2030)
• Figure 14: ECG Telemetry Device Market in Europe (2021-2030)
• Figure 15: ECG Telemetry Device Market in Europe by Country (2021-2030)
• Figure 16: ECG Telemetry Device Market in France (2021-2030)
• Figure 17: ECG Telemetry Device Market in Germany (2021-2030)
• Figure 18: ECG Telemetry Device Market in the United Kingdom (2021-2030)
• Figure 19: ECG Telemetry Device Market in Italy (2021-2030)
• Figure 20: ECG Telemetry Device Market in Spain (2021-2030)
• Figure 21: ECG Telemetry Device Market in the Rest of Europe (2021-2030)
• Figure 22: ECG Telemetry Device Market in Asia-Pacific (2021-2030)
• Figure 23: ECG Telemetry Device Market in Asia-Pacific by Country (2021-2030)
• Figure 24: ECG Telemetry Device Market in China (2021-2030)
• Figure 25: ECG Telemetry Device Market in Japan (2021-2030)
• Figure 26: ECG Telemetry Device Market in India (2021-2030)
• Figure 27: ECG Telemetry Device Market in Australia (2021-2030)
• Figure 28: ECG Telemetry Device Market in South Korea (2021-2030)
• Figure 29: ECG Telemetry Device Market in Rest of Asia-Pacific (2021-2030)
• Figure 30: ECG Telemetry Device Market in the Rest of the World (2021-2030)
• Figure 31: ECG Telemetry Device Market in RoW by Region (2021-2030)
• Figure 32: ECG Telemetry Device Market in the Middle East (2021-2030)
• Figure 33: ECG Telemetry Device Market in Africa (2021-2030)
• Figure 34: ECG Telemetry Device Market in South America (2021-2030)
• Figure 35: Market Drivers
• Figure 36: Market Barriers
• Figure 37: Marker Opportunities
• Figure 38: PORTER'S Five Force Analysis

ECG Telemetry Devices Market By Product Type (Resting ECG Device, Stress ECG Device, And Others), By Type (Wired And Wireless), By Application (Arrhythmias, Myocardial Ischemia, And Others), By End-User (Homecare Settings, Hospitals, Ambulatory Surgical Centers, And Others), and by geography is expected to advance at a respectable CAGR forecast till 2030 owing to the increasing prevalence of cardiac & pulmonary diseases and the rising information technology (it) application in healthcare industry

The global ECG Telemetry devices market is estimated to grow at a CAGR of 7.29% during the forecast period from 2024 to 2030. The demand for ECG telemetry devices is primarily being boosted by the rising prevalence of coronary heart disease across the globe. Further, the rising cases of patients with chronic diseases, the increasing patient admission in intensive care, increasing awareness about self-assessment of heart rhythm, increasing demand for telemedicine, and innovation in product development among others are thereby contributing to the overall growth of the ECG telemetry devices market during the forecast period from 2024-2030.

ECG Telemetry Devices Market Dynamics:

The ECG telemetry devices market is witnessing a growth in product demand owing to various factors, one of the key factors is the increase in the prevalence of cardiac diseases such as stroke, heart attack, atherosclerosis, and others. For instance, according to the Centers for Disease Control and Prevention (CDC) 2022, every year, about 805,000 people in the United States have a heart attack, out of these, 605,000 people suffer from their first heart attack and nearly 200,000 cases happen to people who already had a heart attack. Thus, the increasing cases of heart attack will increase the demand for Mobile ECG telemetry devices as these devices are used for continuous monitoring of the heart.

The increasing patient engagement and connectivity due to the rising penetration of the Internet of Things (IoT) in the medical devices sector are likely to bode well for the market growth during the forecast period. According to a report published by Internet World Stats, in 2022, nearly 5,385,798,406 users were using the internet and in 2022 approximately 7,932,791,734 users were using the internet on regular basis. The incorporation of the internet with medical devices will, in turn, propel the demand for ECG telemetry devices as these devices are connected to the internet for providing continuous data to patients and physicians so that physicians can diagnose any major changes in the patient body and can treat on time so that major disease can be prevented and in the same way, patients can also analyze an irregularity in heart rhythm and can inform their doctor about their heart condition. Thus, the increasing internet use across the globe will increase the demand for ECG telemetry devices.

The off-sight telemetry saves money for both patients and insurance companies. With ECG telemetry technology, patients can receive monitoring at home, eliminating the cost of an unnecessary hospital stay. Further, these systems also include reminders and adherence trackers, which make it easier for patients to monitor their heart rhythm at home which is extremely important after any surgery. The device also offers the potential to catch heart problems early as compared to other monitoring devices. Thus, owing to the aforementioned factors the demand for ECG telemetry will increase in the market.

Moreover, various strategic steps such as collaboration, acquisitions, and partnership, among others propel the market significantly. For instance, in March 2022, the heart-monitoring electrocardiogram (EKG) app on Fitbit's new Sense smartwatch was cleared by the US Food and Drug Administration.

Therefore, the above-mentioned factors are contributing to the growth of the ECG Telemetry devices market during the forecast period from 2024-2030.

However, security and data breaching concerns, accuracy and false result concern, and others may restrict the ECG telemetry devices market growth.

The ECG telemetry devices market experienced a period of a temporary setback as lockdown restrictions were enforced as a necessary step to curb the spread of COVID-19. The demand for ECG Telemetry devices was disrupted owing to the lack of resources, raw materials, and manpower. However, the demand increased significantly with the availability of ECG telemetry devices over e-commerce platforms. This led to an increased thrust in the manufacturing of ECG Telemetry devices. Also, the ECG telemetry devices provided easy monitoring to patients in a homecare setting, thereby avoiding frequent visits to healthcare professionals for diagnosis. The physicians were able to track the heart rhythm of a patient regularly through the ECG telemetry devices. Henceforth, the afore-said factors propelled the demand for ECG telemetry devices during the pandemic and are estimated to grow similarly during the forecast period.

ECG Telemetry Devices Market Segment Analysis:

ECG Telemetry Devices Market By Product Type (Resting ECG Device, Stress ECG Device, and others), Type (Wired and Wireless), Application (Arrhythmias, Myocardial Ischemia, and Others), End-User (Hospitals, Homecare Settings, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the type segment of the ECG telemetry devices market, the wireless category is expected to amass significant revenue share in the year 2023 because of their ease of use, higher compatibility of wireless technology, significant cost savings, and improved patient safety and quality of care.

This can also be ascribed to the higher utilization of technology to connect ECG telemetry devices to smartphones. Thus, wireless technology is expected to drive this segment over the forecast period availability.

Moreover, the increasing planned activities by the key players will also drive the market of wireless-ECG telemetry devices. For instance, in 2022, Apple launched the wireless Apple Watch Series 8 and the new Apple Watch SE for continuous ECG recording.

Also, in April 2022, Biotricity, a medical diagnostic and healthcare technology player, launched the commercial sales of the Biotres, an FDA-approved wireless wearable extended Holter monitor, a type of ECG telemetry device for up to 30-day wear duration.

Therefore, the advantages offered by Wireless-ECG telemetry devices are predicted to contribute to the increasing demand for this portability type category thereby driving the growth of the overall ECG telemetry devices market during the forecast period.

North America is expected to dominate the overall ECG Telemetry Devices Market:

Among all the regions, North America is estimated to account for the largest share in the ECG telemetry devices market in the year 2023 owing to the key growth factor such as the rising prevalence of chronic diseases such as cardiac & respiratory diseases. The rising government initiatives regarding disease management, awareness of self-diagnosis, increasing incorporation of IoT in the healthcare industry, and others are driving the North America ECG telemetry devices market. Furthermore, high disposable income, sophisticated healthcare infrastructure, regulatory approval for new products, and high awareness also helped the market growth in this region.

Further, the United States holds the major share in North America owing to the increasing cases of arrhythmia due to coronary heart disease, rising prevalence of hypertension, asthma, diabetes, obesity, and others in the US population. For instance, as per the Department of Health New York State (2023), Coronary heart disease (CHD) is the most common type of heart disease, killing approximately 382,820 people annually, in the US. Also, every year about 805,000 Americans have a heart attack. The source also stated that an estimated 18.9% of New Yorkers aged 65 and older reported having some type of Cardiovascular Disease (CVD) in 2020. Thus, the rise in the number of patients suffering from cardiovascular disease will need continuous monitoring which will lead to an increase in the demand for ECG Telemetry devices.

According to the Centers for Disease Control and Prevention (CDC) 2022, almost half of the population, nearly 116 million Americans were diagnosed with hypertension in 2020. Patients suffering from hypertension are more prone to heart disease as high blood pressure may affect heart rhythm and may need continuous monitoring to prevent major consequences. Thus, the increasing prevalence of hypertension will increase the demand for ECG telemetry devices in the region.

Therefore, the factors mentioned above help in boosting regional product demand, thereby driving the North America ECG telemetry devices market forward during the forecast period.

ECG Telemetry Devices Market Key Players:

Some of the key market players operating in the ECG telemetry devices market include NIHON KOHDEN CORPORATION, Baxter, Boston Scientific Corporation, GE HealthCare, Koninklijke Philips N.V. (BioTelemetry), Zio by iRhythm Technologies, Inc, Aerotel Medical Systems Ltd, Medtronic, Mindray Medical India Pvt. Ltd., Medicalgorithmics.com, Scottcare cardiovascular solution, ZOLL Medical Corporation, CONTEC MEDICAL SYSTEMS CO., LTD., dmiecg, Perlong Medical Equipment Co., Ltd., better instrument Co., Ltd., XINDRAY International Corp, Anjue Medical Equipment Co., Ltd., Sino-Hero(Shenzhen)Bio-Medical Electronics Co., Ltd., QT Medical Inc., and others.

Recent Developmental Activities in the ECG Telemetry Devices Market:

In March 2023, iRhythm Technologies announced findings supporting its Zio XT wearable heart monitoring technology. The study concluded that Zio XT demonstrated the lowest likelihood of retesting compared to all other ambulatory cardiac monitors (ACMs). It also recorded the lowest acute healthcare resource utilization compared to all other ACMs.

In January 2022, Philips introduced First At-home, 12-lead ECG Integrated Solution for Decentralized Clinical Trials.

In February 2022, QT Medical announced the launch of Xpress ECG service, the world's first 12-lead ECG home test, to help reduce the risk of exposure to COVID-19 by bringing ECG tests to patients at homes.

Key Takeaways from the ECG Telemetry Devices Market Report Study

Market size analysis for current ECG telemetry devices market size (2023), and market forecast for 5 years (2024-2030).

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the ECG Telemetry devices market.

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global ECG telemetry devices Market.

Various opportunities available for the other competitor in the ECG telemetry devices market space.

What are the top-performing segments in 2023? How these segments will perform in 2030.

Which are the top-performing regions and countries in the current ECG telemetry devices market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for ECG telemetry devices market growth in the coming future?

Target Audience who can be benefited from this ECG Telemetry Devices Market Report Study

ECG telemetry devices products providers

Research organizations and consulting companies

ECG Telemetry devices-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in ECG telemetry devices

Various End-users who want to know more about the ECG telemetry devices market and the latest technological developments in the ECG telemetry devices market.

Frequently Asked Questions for the ECG Telemetry Devices Market:

1. What are ECG telemetry devices?

ECG telemetry devices are devices used in the monitoring of electrical activities of the heart. It is a portable device that continuously monitors a patient's ECG, respiratory rate, and oxygen saturation while automatically transmitting information to a central monitor.

2. What is the market for global ECG telemetry devices?

The global ECG Telemetry devices market is estimated to grow at a CAGR of 7.29% during the forecast period from 2024 to 2030.

3. What are the drivers for the global ECG telemetry devices market?

The demand for ECG telemetry devices is primarily being heightened by the increasing cases of cardiac, respiratory disease, and other chronic diseases around the globe and due to the increasing internet demand in the healthcare industry. In addition, the rising awareness regarding self-diagnosis, the increasing continuous patient connectivity & engagement with the physician, the increasing product launches & approvals, and the innovation in product development thereby contribute to the overall growth of the ECG telemetry devices market during the forecast period from 2024-2030.

4. Who are the key players operating in the global ECG Telemetry devices market?

Some of the key market players operating in the ECG telemetry devices market include NIHON KOHDEN CORPORATION, Baxter, Boston Scientific Corporation, GE HealthCare, Koninklijke Philips N.V. (BioTelemetry), Zio by iRhythm Technologies, Inc, Aerotel Medical Systems Ltd, Medtronic, Mindray Medical India Pvt. Ltd., Medicalgorithmics, Scottcare cardiovascular solution, ZOLL Medical Corporation, CONTEC MEDICAL SYSTEMS CO., LTD., dmiecg, Perlong Medical Equipment Co., Ltd., better instrument Co., Ltd., XINDRAY International Corp, Anjue Medical Equipment Co., Ltd., Sino-Hero(Shenzhen) Bio-Medical Electronics Co., Ltd., QT Medical Inc., and others.

5. Which region has the highest share in the ECG Telemetry devices market?

North America is expected to dominate the overall ECG telemetry devices market during the forecast period from 2024-2030. Factors such as the rising prevalence of chronic diseases, stroke, and hypertension among others, the surging number of an aging population that is more prone to chronic diseases, the rising government initiatives regarding disease management, the increasing awareness of self-measurement of the cardiac activity, and others will propel the North American ECG telemetry devices market. Furthermore, high disposable income, sophisticated healthcare infrastructure, regulatory approval for new devices, and high awareness also helped the market growth in this region.

Table of Contents

1. ECG Telemetry Device Market Report Introduction

2. Market Executive Summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment

3. Regulatory Analysis

• 3.1. The United States
• 3.2. Europe
• 3.3. Japan
• 3.4. China

4. ECG Telemetry Device Market Key Factors Analysis

• 4.1. ECG Telemetry Device Market Drivers
  • 4.1.1. The growing incorporation of IoT in the healthcare industry
  • 4.1.2. Increasing prevalence of cardiovascular diseases
  • 4.1.3. An increasing number of home care monitoring devices
• 4.2. ECG Telemetry Device Market Restraints and Challenges
  • 4.2.1. Accuracy and false result concern
  • 4.2.2. Security and data breaching concerns
• 4.3. ECG Telemetry Device Market Opportunities
  • 4.3.1. Increasing artificial intelligence in ECG telemetry device

5. ECG Telemetry Device Market Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. Threat of New Entrants
• 5.4. Threat of Substitutes
• 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on ECG Telemetry Device Market

7. ECG Telemetry Device Market Layout

• 7.1. By Product Type
  • 7.1.1. Resting ECG Devices
  • 7.1.2. Stress ECG Devices
  • 7.1.3. Others
• 7.2. By Type
  • 7.2.1. Wired
  • 7.2.2. Wireless
• 7.3. By Application
  • 7.3.1. Arrhythmias
  • 7.3.2. Myocardial Ischemia
  • 7.3.3. Others
• 7.4. By End-User
  • 7.4.1. Home Care Settings
  • 7.4.2. Hospitals
  • 7.4.3. Ambulatory Surgical Centers
  • 7.4.4. Others
• 7.5. By Geography
  • 7.5.1. North America ECG Telemetry Device Market Size in USD million (2021-2030)
    • 7.5.1.1. United States ECG Telemetry Device Market Size in USD million (2021-2030)
    • 7.5.1.2. Canada ECG Telemetry Device Market Size in USD million (2021-2030)
    • 7.5.1.3. Mexico ECG Telemetry Device Market Size in USD million (2021-2030)
  • 7.5.2. Europe ECG Telemetry Device Market Size in USD million (2021-2030)
    • 7.5.2.1. France ECG Telemetry Device Market Size in USD million (2021-2030)
    • 7.5.2.2. Germany ECG Telemetry Device Market Size in USD million (2021-2030)
    • 7.5.2.3. United Kingdom ECG Telemetry Device Market Size in USD million (2021-2030)
    • 7.5.2.4. Italy ECG Telemetry Device Market Size in USD million (2021-2030)
    • 7.5.2.5. Spain ECG Telemetry Device Market Size in USD million (2021-2030)
    • 7.5.2.6. Rest of Europe ECG Telemetry Device Market Size in USD million (2021-2030)
  • 7.5.3. Asia-Pacific ECG Telemetry Device Market Size in USD million (2021-2030)
    • 7.5.3.1. China ECG Telemetry Device Market Size in USD million (2021-2030)
    • 7.5.3.2. Japan ECG Telemetry Device Market Size in USD million (2021-2030)
    • 7.5.3.3. India ECG Telemetry Device Market Size in USD million (2021-2030)
    • 7.5.3.4. Australia ECG Telemetry Device Market Size in USD million (2021-2030)
    • 7.5.3.5. South Korea ECG Telemetry Device Market Size in USD million (2021-2030)
    • 7.5.3.6. Rest of Asia-Pacific ECG Telemetry Device Market Size in USD million (2021-2030)
  • 7.5.4. Rest of the World (RoW) ECG Telemetry Device Market Size in USD million (2021-2030)
    • 7.5.4.1. Middle East ECG Telemetry Device Market Size in USD million (2021-2030)
    • 7.5.4.2. Africa ECG Telemetry Device Market Size in USD million (2021-2030)
    • 7.5.4.3. South America ECG Telemetry Device Market Size in USD million (2021-2030)

8. ECG Telemetry Device Market Company and Product Profiles

• 8.1. NIHON KOHDEN CORPORATION
  • 8.1.1. Company Overview
  • 8.1.2. Company Snapshot
  • 8.1.3. Financial Overview
  • 8.1.4. Product Listing
  • 8.1.5. Entropy
• 8.2. Baxter
  • 8.2.1. Company Overview
  • 8.2.2. Company Snapshot
  • 8.2.3. Financial Overview
  • 8.2.4. Product Listing
  • 8.2.5. Entropy
• 8.3. Boston Scientific Corporation
  • 8.3.1. Company Overview
  • 8.3.2. Company Snapshot
  • 8.3.3. Financial Overview
  • 8.3.4. Product Listing
  • 8.3.5. Entropy
• 8.4. GE HealthCare
  • 8.4.1. Company Overview
  • 8.4.2. Company Snapshot
  • 8.4.3. Financial Overview
  • 8.4.4. Product Listing
  • 8.4.5. Entropy
• 8.5. Koninklijke Philips N.V. (BioTelemetry)
  • 8.5.1. Company Overview
  • 8.5.2. Company Snapshot
  • 8.5.3. Financial Overview
  • 8.5.4. Product Listing
  • 8.5.5. Entropy
• 8.6. Zio by iRhythm Technologies, Inc.
  • 8.6.1. Company Overview
  • 8.6.2. Company Snapshot
  • 8.6.3. Financial Overview
  • 8.6.4. Product Listing
  • 8.6.5. Entropy
• 8.7. Aerotel Medical Systems Ltd
  • 8.7.1. Company Overview
  • 8.7.2. Company Snapshot
  • 8.7.3. Financial Overview
  • 8.7.4. Product Listing
  • 8.7.5. Entropy
• 8.8. Medtronic
  • 8.8.1. Company Overview
  • 8.8.2. Company Snapshot
  • 8.8.3. Financial Overview
  • 8.8.4. Product Listing
  • 8.8.5. Entropy
• 8.9. Mindray Medical India Pvt. Ltd.
  • 8.9.1. Company Overview
  • 8.9.2. Company Snapshot
  • 8.9.3. Financial Overview
  • 8.9.4. Product Listing
  • 8.9.5. Entropy
• 8.10. Medicalgorithmics
  • 8.10.1. Company Overview
  • 8.10.2. Company Snapshot
  • 8.10.3. Financial Overview
  • 8.10.4. Product Listing
  • 8.10.5. Entropy
• 8.11. Scottcare cardiovascular solution
  • 8.11.1. Company Overview
  • 8.11.2. Company Snapshot
  • 8.11.3. Financial Overview
  • 8.11.4. Product Listing
  • 8.11.5. Entropy
• 8.12. ZOLL Medical Corporation
  • 8.12.1. Company Snapshot
  • 8.12.2. Financial Overview
  • 8.12.3. Product Listing
  • 8.12.4. Entropy
• 8.13. CONTEC MEDICAL SYSTEMS CO., LTD.
  • 8.13.1. Company Overview
  • 8.13.2. Company Snapshot
  • 8.13.3. Financial Overview
  • 8.13.4. Product Listing
  • 8.13.5. Entropy
• 8.14. dmiecg
  • 8.14.1. Company Overview
  • 8.14.2. Company Snapshot
  • 8.14.3. Financial Overview
  • 8.14.4. Product Listing
  • 8.14.5. Entropy
• 8.15. Perlong Medical Equipment Co., Ltd.
  • 8.15.1. Company Overview
  • 8.15.2. Company Snapshot
  • 8.15.3. Financial Overview
  • 8.15.4. Product Listing
  • 8.15.5. Entropy
• 8.16. QT Medical Inc.
  • 8.16.1. Company Overview
  • 8.16.2. Company Snapshot
  • 8.16.3. Financial Overview
  • 8.16.4. Product Listing
  • 8.16.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us